- Home
- BODI vs ANTX Comparison
BODI vs ANTX Comparison
Compare BODI & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- ANTX
- Stock Information
- Founded
- BODI 1998
- ANTX 2017
- Country
- BODI United States
- ANTX United States
- Employees
- BODI N/A
- ANTX N/A
- Industry
- BODI Industrial Machinery/Components
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- ANTX Health Care
- Exchange
- BODI Nasdaq
- ANTX Nasdaq
- Market Cap
- BODI 25.4M
- ANTX 33.2M
- IPO Year
- BODI N/A
- ANTX 2022
- Fundamental
- Price
- BODI $4.55
- ANTX $1.08
- Analyst Decision
- BODI Buy
- ANTX Buy
- Analyst Count
- BODI 2
- ANTX 2
- Target Price
- BODI $10.00
- ANTX $2.00
- AVG Volume (30 Days)
- BODI 16.8K
- ANTX 71.3K
- Earning Date
- BODI 08-05-2025
- ANTX 08-12-2025
- Dividend Yield
- BODI N/A
- ANTX N/A
- EPS Growth
- BODI N/A
- ANTX N/A
- EPS
- BODI N/A
- ANTX N/A
- Revenue
- BODI $371,113,000.00
- ANTX N/A
- Revenue This Year
- BODI N/A
- ANTX N/A
- Revenue Next Year
- BODI N/A
- ANTX N/A
- P/E Ratio
- BODI N/A
- ANTX N/A
- Revenue Growth
- BODI N/A
- ANTX N/A
- 52 Week Low
- BODI $3.38
- ANTX $0.87
- 52 Week High
- BODI $8.71
- ANTX $2.73
- Technical
- Relative Strength Index (RSI)
- BODI 60.10
- ANTX 46.34
- Support Level
- BODI $3.81
- ANTX $1.07
- Resistance Level
- BODI $4.79
- ANTX $1.16
- Average True Range (ATR)
- BODI 0.30
- ANTX 0.03
- MACD
- BODI 0.06
- ANTX 0.00
- Stochastic Oscillator
- BODI 62.73
- ANTX 23.58
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.